Hesperidin and icaritin exhibit potential in suppressing PD-L1 expression in various cancer cells, including estrogen-dependent triple-negative breast cancer and androgen-dependent prostate cancer cells. This evidence concerns the gene CD274 and Familial prostate cancer.